Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This non-randomized study will test the safety and effectiveness of Genasense in patients with CLL.

Phase 1/Phase 2

Genta Incorporated